MAXHEALTH share price target 2026

BazaarBaazi does not publish a SEBI-registered price target on MAXHEALTH. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 21 Jul 2026.

The BazaarBaazi Crack Score for MAXHEALTH is 89 out of 100 as of 25 Jul 2026, a high conviction reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.

Strike-level option inventory for MAXHEALTH is unavailable, so BazaarBaazi withholds participant, direction and positioning claims. The editorial chart stance is not substituted for an option-chain observation.

MAXHEALTH sits in Healthcare (large cap), indicative market cap ~1.1 lakh cr (indicative), ISIN INE027H01010. The peers BazaarBaazi reads alongside it are GLAND PHARMA LIMITED, Eris Lifesciences Limited, ACUTAAS CHEMICALS LIMITED. A systematic, data-only read on Max Healthcare Institute Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.

This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on MAXHEALTH is bullish, published in Systematic Read on 21 Jul 2026.

On the 2026-07-24 run of the 500-name BazaarBaazi setup scanner, Max Healthcare Institute Limited sits in the Scanned tier with a setup score of 75/100 (technical 87, fundamental 84). The scanner is a deterministic engine over real OHLCV and official filings, refreshed nightly, and it is a signal rather than investment advice.

BazaarBaazi indexes 21 MAXHEALTH earnings calls going back to 2020-09-30, latest 2026-05-31. Every entry on this page links straight to the transcript PDF the company filed with the exchange, so you read management in the primary source.

Max Healthcare Institute Limited reported a net profit of Rs 342 cr for Q4 FY26 (the quarter ended 31 March 2026). That is +7.3% year on year. The figure is from the company's official NSE filing.

Max Healthcare Institute Limited reported revenue of Rs 2,143 cr for Q4 FY26. That is +12.2% year on year. The figure is from the company's official NSE filing.

BazaarBaazi gives Max Healthcare Institute Limited's Q4 FY26 result a Result Pulse of 76 out of 100, with a verdict of Margin expansion. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.

Max Healthcare Institute Ltd's two most material recent disclosures are a regulatory dated 10 Jul 2026, "Certificate under SEBI (Depositories and Participants)…", and an agm / egm dated 09 Jul 2026, "newspaper publication in relation to Notice of 25th…". Both link to the company's own official filing on the BazaarBaazi stock page.

Yes. Max Healthcare Institute Ltd filed a dividend disclosure on 03 Jul 2026, filed as "Dividend - Rs 2 Per Share". Any amount shown is the exchange's own record, linked from the BazaarBaazi stock page. A dividend is a declared payout, not a forecast of future returns.

Max Healthcare Institute Ltd's most recent board-meeting disclosure on record dated 08 Jul 2026 reads "Notice of Annual General Meeting to be held on July 30, 2026". That is the agenda as filed with the exchange, linked from the BazaarBaazi stock page, and BazaarBaazi adds no claim of its own to it.